Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 291

1.

Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection.

Laiño J, Villena J, Suvorov A, Zelaya H, Ortiz Moyano R, Salva S, Alvarez S.

PLoS One. 2018 Nov 5;13(11):e0206661. doi: 10.1371/journal.pone.0206661. eCollection 2018.

2.

Firefly genomes illuminate parallel origins of bioluminescence in beetles.

Fallon TR, Lower SE, Chang CH, Bessho-Uehara M, Martin GJ, Bewick AJ, Behringer M, Debat HJ, Wong I, Day JC, Suvorov A, Silva CJ, Stanger-Hall KF, Hall DW, Schmitz RJ, Nelson DR, Lewis SM, Shigenobu S, Bybee SM, Larracuente AM, Oba Y, Weng JK.

Elife. 2018 Oct 16;7. pii: e36495. doi: 10.7554/eLife.36495.

3.

Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Permanently Alters Blood-Liver Balance of Lipids in Male Mice.

Khalil A, Cevik SE, Hung S, Kolla S, Roy MA, Suvorov A.

Front Endocrinol (Lausanne). 2018 Sep 20;9:548. doi: 10.3389/fendo.2018.00548. eCollection 2018.

4.

Autoprobiotics as an Approach for Restoration of Personalised Microbiota.

Suvorov A, Karaseva A, Kotyleva M, Kondratenko Y, Lavrenova N, Korobeynikov A, Kozyrev P, Kramskaya T, Leontieva G, Kudryavtsev I, Guo D, Lapidus A, Ermolenko E.

Front Microbiol. 2018 Sep 12;9:1869. doi: 10.3389/fmicb.2018.01869. eCollection 2018.

5.

[The intestinal microbiota composition in patients with multiple sclerosis receiving different disease-modifying therapies DMT].

Abdurasulova IN, Tarasova EA, Nikiforova IG, Il'ves AG, Ivashkova EV, Matsulevich AV, Tatarinov AE, Shangina LV, Ermolenko EI, Klimenko VM, Stolyarov ID, Suvorov AN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8. Vyp. 2):62-69. doi: 10.17116/jnevro201811808262. Russian.

PMID:
30160670
6.

Anti-Influenza Activity of Enterocin B In vitro and Protective Effect of Bacteriocinogenic Enterococcal Probiotic Strain on Influenza Infection in Mouse Model.

Ermolenko EI, Desheva YA, Kolobov AA, Kotyleva MP, Sychev IA, Suvorov AN.

Probiotics Antimicrob Proteins. 2018 Aug 24. doi: 10.1007/s12602-018-9457-0. [Epub ahead of print]

PMID:
30143997
7.

Influence of monostrain and multistrain probiotics on immunity, intestinal ultrastructure and microbiota in experimental dysbiosis.

Ermolenko E, Rybalchenko O, Borshev Y, Tarasova E, Kramskaya T, Leontieva G, Kotyleva M, Orlova O, Abdurasulova I, Suvorov A.

Benef Microbes. 2018 Aug 13:1-14. doi: 10.3920/BM2017.0117. [Epub ahead of print]

PMID:
30099893
8.

Development of experimental GBS vaccine for mucosal immunization.

Gupalova T, Leontieva G, Kramskaya T, Grabovskaya K, Bormotova E, Korjevski D, Suvorov A.

PLoS One. 2018 May 4;13(5):e0196564. doi: 10.1371/journal.pone.0196564. eCollection 2018. Erratum in: PLoS One. 2018 Jun 1;13(6):e0198577.

9.

Modeling of 3D Structure of Chimeric Constructs Based on Hemagglutinin of Influenza Virus and Immunogenic Epitopes of Streptococcus Agalactiae.

Fedorova EA, Smolonogina TA, Isakova-Sivak IN, Koren'kov DA, Kotomina TS, Leont'eva GF, Suvorov AN, Rudenko LG.

Bull Exp Biol Med. 2018 Apr;164(6):743-748. doi: 10.1007/s10517-018-4071-4. Epub 2018 Apr 16.

PMID:
29658084
10.
11.

Peripubertal serum dioxin concentrations and subsequent sperm methylome profiles of young Russian adults.

Pilsner JR, Shershebnev A, Medvedeva YA, Suvorov A, Wu H, Goltsov A, Loukianov E, Andreeva T, Gusev F, Manakhov A, Smigulina L, Logacheva M, Shtratnikova V, Kuznetsova I, Speranskiy-Podobed P, Burns JS, Williams PL, Korrick S, Lee MM, Rogaev E, Hauser R, Sergeyev O.

Reprod Toxicol. 2018 Jun;78:40-49. doi: 10.1016/j.reprotox.2018.03.007. Epub 2018 Mar 14.

PMID:
29550351
12.

Inactivation of M111 Protein Gene Modifies Streptococcus Pyogenes Interactions with Mouse Macrophages In Vitro.

Suvorova MA, Kramskaya TA, Suvorov AN, Kiseleva EP.

Bull Exp Biol Med. 2018 Jan;164(3):347-350. doi: 10.1007/s10517-018-3987-z. Epub 2018 Jan 8.

PMID:
29308558
13.

Developmental Exposure to 2,2',4,4'-Tetrabromodiphenyl Ether Induces Long-Lasting Changes in Liver Metabolism in Male Mice.

Khalil A, Parker M, Mpanga R, Cevik SE, Thorburn C, Suvorov A.

J Endocr Soc. 2017 Mar 14;1(4):323-344. doi: 10.1210/js.2016-1011. eCollection 2017 Apr 1.

14.

Correction to: Parma consensus statement on metabolic disruptors.

Heindel JJ, Vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, Cohn BA, Fabbri E, Gioiosa L, Kassotis C, Legler J, La Merrill M, Rizzi L, Machtinger R, Mantovani A, Mendez MA, Montanini L, Molteni L, Nagel SC, Parmigiani S, Panzica G, Paterlini S, Pomatto V, Ruzzin J, Sartor G, Schug TT, Street ME, Suvorov A, Volpi R, Zoeller RT, Palanza P.

Environ Health. 2017 Dec 6;16(1):130. doi: 10.1186/s12940-017-0343-0.

15.

Perinatal exposure to low dose 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) alters sperm DNA methylation in adult rats.

Suvorov A, Shershebnev A, Wu H, Medvedeva Y, Sergeyev O, Pilsner JR.

Reprod Toxicol. 2018 Jan;75:136-143. doi: 10.1016/j.reprotox.2017.10.009. Epub 2017 Oct 28.

PMID:
29107676
16.

Preconception urinary phthalate concentrations and sperm DNA methylation profiles among men undergoing IVF treatment: a cross-sectional study.

Wu H, Estill MS, Shershebnev A, Suvorov A, Krawetz SA, Whitcomb BW, Dinnie H, Rahil T, Sites CK, Pilsner JR.

Hum Reprod. 2017 Nov 1;32(11):2159-2169. doi: 10.1093/humrep/dex283.

17.

Complete Genome Sequences of emm111 Type Streptococcus pyogenes Strain GUR, with Antitumor Activity, and Its Derivative Strain GURSA1 with an Inactivated emm Gene.

Suvorova MA, Tsapieva AN, Bak EG, Chereshnev VA, Kiseleva EP, Suvorov AN, Arumugam M.

Genome Announc. 2017 Sep 21;5(38). pii: e00939-17. doi: 10.1128/genomeA.00939-17.

18.

Perinatal exposure to 2,2',4'4' -Tetrabromodiphenyl ether induces testicular toxicity in adult rats.

Khalil A, Parker M, Brown SE, Cevik SE, Guo LW, Jensen J, Olmsted A, Portman D, Wu H, Suvorov A.

Toxicology. 2017 Aug 15;389:21-30. doi: 10.1016/j.tox.2017.07.006. Epub 2017 Jul 13.

PMID:
28712647
19.

Feminization of male mouse liver by persistent growth hormone stimulation: Activation of sex-biased transcriptional networks and dynamic changes in chromatin states.

Lau-Corona D, Suvorov A, Waxman DJ.

Mol Cell Biol. 2017 Jul 10. pii: MCB.00301-17. doi: 10.1128/MCB.00301-17. [Epub ahead of print]

20.

Prevention of Influenza A(H7N9) and Bacterial Infections in Mice Using Intranasal Immunization With Live Influenza Vaccine and the Group B Streptococcus Recombinant Polypeptides.

Desheva YA, Leontieva GF, Kramskaya TA, Smolonogina TA, Grabovskaya KB, Landgraf GO, Karev VE, Suvorov AN, Rudenko LG.

Virology (Auckl). 2017 Jun 6;8:1178122X17710949. doi: 10.1177/1178122X17710949. eCollection 2017.

21.

Emergent Optical Phononic Modes upon Nanoscale Mesogenic Phase Transitions.

Bolmatov D, Zhernenkov M, Sharpnack L, Agra-Kooijman DM, Kumar S, Suvorov A, Pindak R, Cai YQ, Cunsolo A.

Nano Lett. 2017 Jun 14;17(6):3870-3876. doi: 10.1021/acs.nanolett.7b01324. Epub 2017 Jun 2.

PMID:
28548861
22.

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment.

Dimopoulos MA, Stewart AK, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel D, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak A, San-Miguel J, Ludwig H, Ro S, Aggarwal S, Moreau P, Palumbo A.

Blood Cancer J. 2017 Apr 21;7(4):e554. doi: 10.1038/bcj.2017.31.

23.

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial.

Mesa RA, Vannucchi AM, Mead A, Egyed M, Szoke A, Suvorov A, Jakucs J, Perkins A, Prasad R, Mayer J, Demeter J, Ganly P, Singer JW, Zhou H, Dean JP, Te Boekhorst PA, Nangalia J, Kiladjian JJ, Harrison CN.

Lancet Haematol. 2017 May;4(5):e225-e236. doi: 10.1016/S2352-3026(17)30027-3. Epub 2017 Mar 20.

PMID:
28336242
24.

Clinical strains of Streptococcus agalactiae carry two different variants of pathogenicity island XII.

Kuleshevich E, Ferretti J, Santos Sanches I, Balasubramanian N, Spellerberg B, Efstratiou A, Kriz P, Grabovskaya K, Arjanova O, Savitcheva A, Shevchenko V, Rysev A, Suvorov A.

Folia Microbiol (Praha). 2017 Sep;62(5):393-399. doi: 10.1007/s12223-017-0509-8. Epub 2017 Mar 18.

PMID:
28315021
25.

Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup.

Ludwig H, Dimopoulos MA, Moreau P, Chng WJ, Goldschmidt H, Hájek R, Facon T, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Palumbo A, Gillenwater HH, Mohamed N, Aggarwal S, Feng S, Joshua D.

Leuk Lymphoma. 2017 Oct;58(10):2501-2504. doi: 10.1080/10428194.2017.1298755. Epub 2017 Mar 17. No abstract available.

PMID:
28306371
26.

Spermatogenesis disruption by dioxins: Epigenetic reprograming and windows of susceptibility.

Pilsner JR, Parker M, Sergeyev O, Suvorov A.

Reprod Toxicol. 2017 Apr;69:221-229. doi: 10.1016/j.reprotox.2017.03.002. Epub 2017 Mar 7. Review.

27.

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.

Dimopoulos MA, Stewart AK, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel D, Mihaylov GG, Goranova-Marinova V, Rajnics P, Suvorov A, Niesvizky R, Jakubowiak A, San-Miguel J, Ludwig H, Palumbo A, Obreja M, Aggarwal S, Moreau P.

Br J Haematol. 2017 May;177(3):404-413. doi: 10.1111/bjh.14549. Epub 2017 Feb 17.

28.

Overcoming the loss of blue sensitivity through opsin duplication in the largest animal group, beetles.

Sharkey CR, Fujimoto MS, Lord NP, Shin S, McKenna DD, Suvorov A, Martin GJ, Bybee SM.

Sci Rep. 2017 Jan 31;7(1):8. doi: 10.1038/s41598-017-00061-7.

29.

Carfilzomib-dexamethasone vs bortezomib-dexamethasone in relapsed or refractory multiple myeloma by cytogenetic risk in the phase 3 study ENDEAVOR.

Chng WJ, Goldschmidt H, Dimopoulos MA, Moreau P, Joshua D, Palumbo A, Facon T, Ludwig H, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Gillenwater HH, Mohamed N, Feng S, Aggarwal S, Hájek R.

Leukemia. 2017 Jun;31(6):1368-1374. doi: 10.1038/leu.2016.390. Epub 2016 Dec 27.

31.

Evaluation in Mouse Model of Combined Virus-bacterial Vaccine Based on Attenuated Influenza A(H7N3) Virus and the Group B Streptococcus Recombinant Polypeptides.

Desheva YA, Leontieva GF, Kramskaya TA, Smolonogina TA, Grabovskaya KB, Kiseleva IV, Rudenko LG, Suvorov AN.

Open Microbiol J. 2016 Oct 31;10:168-175. eCollection 2016.

32.

[INFLUENCE OF PROBIOTIC STRAIN E. FAECIUM L3 ON MYOCARDIAL TOLERANCE TO ISCHEMIA-REPERFUSION INJURY IN THE MODEL OF ANTIBIOTIC-INDUCED INTESTINAL DYSBIOSIS].

Borshcev YY, Minasian SM, Burovenko IY, Ermolenko EI, Suvorov AN, Galagudza MM.

Ross Fiziol Zh Im I M Sechenova. 2016 Nov;102(11):1323-32. Russian.

PMID:
30193448
33.

Odonata (dragonflies and damselflies) as a bridge between ecology and evolutionary genomics.

Bybee S, Córdoba-Aguilar A, Duryea MC, Futahashi R, Hansson B, Lorenzo-Carballa MO, Schilder R, Stoks R, Suvorov A, Svensson EI, Swaegers J, Takahashi Y, Watts PC, Wellenreuther M.

Front Zool. 2016 Oct 10;13:46. eCollection 2016. Review.

34.

Opsins have evolved under the permanent heterozygote model: insights from phylotranscriptomics of Odonata.

Suvorov A, Jensen NO, Sharkey CR, Fujimoto MS, Bodily P, Wightman HM, Ogden TH, Clement MJ, Bybee SM.

Mol Ecol. 2017 Mar;26(5):1306-1322. doi: 10.1111/mec.13884. Epub 2016 Nov 5.

PMID:
27758014
35.

Enterococcus faecium strain L-3 and glatiramer acetate ameliorate experimental allergic encephalomyelitis in rats by affecting different populations of immune cells.

Abdurasulova IN, Matsulevich AV, Tarasova EA, Kudryavtsev IV, Serebrjakova MK, Ermolenko EI, Bisaga GN, Klimenko VM, Suvorov AN.

Benef Microbes. 2016 Nov 30;7(5):719-729. Epub 2016 Sep 16.

PMID:
27633171
36.

The OGCleaner: filtering false-positive homology clusters.

Fujimoto MS, Suvorov A, Jensen NO, Clement MJ, Snell Q, Bybee SM.

Bioinformatics. 2017 Jan 1;33(1):125-127. doi: 10.1093/bioinformatics/btw571. Epub 2016 Sep 10.

PMID:
27614349
37.

Reply to "Isolating Viable Ancient Bacteria: What You Put In Is What You Get Out".

Goncharov A, Grigorjev S, Karaseva A, Kolodzhieva V, Azarov D, Akhremenko Y, Tarasova L, Tikhonov A, Masharskiy A, Zueva L, Suvorov A.

Genome Announc. 2016 Aug 25;4(4). pii: e00734-16. doi: 10.1128/genomeA.00734-16. No abstract available.

38.

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study.

Moreau P, Joshua D, Chng WJ, Palumbo A, Goldschmidt H, Hájek R, Facon T, Ludwig H, Pour L, Niesvizky R, Oriol A, Rosiñol L, Suvorov A, Gaidano G, Pika T, Weisel K, Goranova-Marinova V, Gillenwater HH, Mohamed N, Aggarwal S, Feng S, Dimopoulos MA.

Leukemia. 2017 Jan;31(1):115-122. doi: 10.1038/leu.2016.186. Epub 2016 Jul 4.

39.

A cure for the blues: opsin duplication and subfunctionalization for short-wavelength sensitivity in jewel beetles (Coleoptera: Buprestidae).

Lord NP, Plimpton RL, Sharkey CR, Suvorov A, Lelito JP, Willardson BM, Bybee SM.

BMC Evol Biol. 2016 May 18;16(1):107. doi: 10.1186/s12862-016-0674-4.

40.

Final overall survival results of a randomized trial comparing bortezomib plus pegylated liposomal doxorubicin with bortezomib alone in patients with relapsed or refractory multiple myeloma.

Orlowski RZ, Nagler A, Sonneveld P, Bladé J, Hajek R, Spencer A, Robak T, Dmoszynska A, Horvath N, Spicka I, Sutherland HJ, Suvorov AN, Xiu L, Cakana A, Parekh T, San-Miguel JF.

Cancer. 2016 Jul 1;122(13):2050-6. doi: 10.1002/cncr.30026. Epub 2016 May 18.

41.

Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin may alter LH release patterns by abolishing sex differences in GABA/glutamate cell number and modifying the transcriptome of the male anteroventral periventricular nucleus.

Del Pino Sans J, Clements KJ, Suvorov A, Krishnan S, Adams HL, Petersen SL.

Neuroscience. 2016 Aug 4;329:239-53. doi: 10.1016/j.neuroscience.2016.04.051. Epub 2016 May 13.

PMID:
27185484
42.

To Cull or Not To Cull? Considerations for Studies of Endocrine-Disrupting Chemicals.

Suvorov A, Vandenberg LN.

Endocrinology. 2016 Jul;157(7):2586-94. doi: 10.1210/en.2016-1145. Epub 2016 May 13. Review.

43.

[EFFECT OF PROBIOTIC ENTEROCOCCI AND GLATIRAMER ACETATE ON THE SEVERITY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RATS ].

Abdurasulova IN, Ermolenko EI, Matsulevich AV, Abdurasulova KO, Tarasova EA, Kudryavtsev IV, Bisaga GN, Suvorov AN, Klimenko VM.

Ross Fiziol Zh Im I M Sechenova. 2016 Apr;102(4):463-79. Russian.

PMID:
30189124
44.

[CHANGES IN THE QUALITATIVE AND QUANTITATIVE COMPOSITION OF GUT MICROBIOTA IN RATS DURING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS].

Abdurasulova IN, Tarasova EA, Matsulevich AV, Eliseev AV, Ermolenko EI, Suvorov AN, Klimenko VM.

Ross Fiziol Zh Im I M Sechenova. 2015 Nov;101(11):1235-49. Russian.

PMID:
26995952
46.

Detecting false positive sequence homology: a machine learning approach.

Fujimoto MS, Suvorov A, Jensen NO, Clement MJ, Bybee SM.

BMC Bioinformatics. 2016 Feb 24;17:101. doi: 10.1186/s12859-016-0955-3.

47.

Draft Genome Sequence of Enterococcus faecium Strain 58m, Isolated from Intestinal Tract Content of a Woolly Mammoth, Mammuthus primigenius.

Goncharov A, Grigorjev S, Karaseva A, Kolodzhieva V, Azarov D, Akhremenko Y, Tarasova L, Tikhonov A, Masharskiy A, Zueva L, Suvorov A.

Genome Announc. 2016 Feb 11;4(1). pii: e01706-15. doi: 10.1128/genomeA.01706-15.

48.

Draft Genome Sequence of Probiotic Enterococcus faecium Strain L-3.

Karaseva A, Tsapieva A, Pachebat J, Suvorov A.

Genome Announc. 2016 Jan 28;4(1). pii: e01622-15. doi: 10.1128/genomeA.01622-15.

49.

Ultrahigh energy resolution focusing monochromator for inelastic x-ray scattering spectrometer.

Suvorov A, Cunsolo A, Chubar O, Cai YQ.

Opt Express. 2015 Nov 30;23(24):31607-18. doi: 10.1364/OE.23.031607.

PMID:
26698784
50.

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

Dimopoulos MA, Moreau P, Palumbo A, Joshua D, Pour L, Hájek R, Facon T, Ludwig H, Oriol A, Goldschmidt H, Rosiñol L, Straub J, Suvorov A, Araujo C, Rimashevskaya E, Pika T, Gaidano G, Weisel K, Goranova-Marinova V, Schwarer A, Minuk L, Masszi T, Karamanesht I, Offidani M, Hungria V, Spencer A, Orlowski RZ, Gillenwater HH, Mohamed N, Feng S, Chng WJ; ENDEAVOR Investigators.

Lancet Oncol. 2016 Jan;17(1):27-38. doi: 10.1016/S1470-2045(15)00464-7. Epub 2015 Dec 5.

Supplemental Content

Loading ...
Support Center